
What can hospitals miss when they focus on CLABSI rates? The authors examine how broader surveillance of bloodstream infections could help link potentially preventable catheter-related infections to longer stays, higher costs, and discharge needs.
Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.
Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.







